Harvard Bioscience Announces Second Quarter 2026 Financial Results
Go back to Harvard Bioscience Announces Second Quarter 2026 Financial Results| Harvard Bioscience, Inc. (NASDAQ: HBIO) | Delayed: 7.55 +0.47 (6.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.08 | 52 Week High | $3.90 | |||
| Open | $6.94 | 52 Week Low | $2.25 | |||
| Day High | $7.63 | P/E | N/A | |||
| Day Low | $6.94 | EPS | $-0.03 | |||
| Volume | 52,267 | |||||

